טוען...
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
BACKGROUND: Allergen immunotherapy (AIT) is the only causal therapy for IgE-mediated allergy. There is less evidence about the safety and efficacy of AIT especially subcutaneous immunotherapy (SCIT) in children under 5 years old. We aimed to investigate the side effects and associated risk factors o...
שמור ב:
| הוצא לאור ב: | Ital J Pediatr |
|---|---|
| Main Authors: | , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8063484/ https://ncbi.nlm.nih.gov/pubmed/33892756 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13052-021-01046-z |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|